About Harrow
Harrow is a company based in Nashville (United States) founded in 2012. It operates as a Direct-to-Consumer (D2C) and Professional Services. The company has 382 employees as of December 31, 2024. Harrow has completed 1 acquisition, including Melt Pharmaceuticals. Harrow offers products and services including Ophthalmic Medications, Compounding Business, and Branded Therapies. Harrow operates in a competitive market with competitors including Cardinal Health, Moxie, Orbital Therapeutics, CG Life and W2O Group, among others.
- Headquarter Nashville, United States
- Employees 382 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Harrow, Inc.
-
Annual Revenue
$199.61 M (USD)53.32as on Dec 31, 2024
-
Net Profit
-$17.48 M (USD)28.39as on Dec 31, 2024
-
EBITDA
$22.89 M (USD)77.17as on Dec 31, 2024
-
Latest Funding Round
$10.7 M (USD), Post-IPO
May 01, 2021
- Investors
-
Employee Count
382
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Harrow
Harrow is a publicly listed company on the NASDAQ with ticker symbol HROW in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Harrow
Harrow offers a comprehensive portfolio of products and services, including Ophthalmic Medications, Compounding Business, and Branded Therapies.
Essential medications for eyecare are provided by Harrow.
Specialized compounding solutions for eyecare are offered here.
Proven branded therapies for vision are delivered by Harrow.
People of Harrow
Unlock access to complete
Unlock access to complete
Funding Insights of Harrow
Investors in Harrow
Harrow has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include B. Riley Financial.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Mergers, acquisitions, capital raising, and strategic advisory services are provided.
|
Locked | Locked | Locked |
Investor details for Harrow
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Harrow
Harrow has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Melt Pharmaceuticals.
Investment portfolio details for Harrow
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pharmaceutical solutions are developed by Melt Pharmaceuticals in the US.
|
Locked | Locked | 2018 | Locked |
Complete acquisition details for Harrow
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Harrow
Detailed financials for Harrow
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Harrow Comparisons
Peer comparison for Harrow
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Harrow
Harrow operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardinal Health, Moxie, Orbital Therapeutics, CG Life and W2O Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Multiple healthcare products and services are provided to organizations.
|
|
| Locked | Locked | Locked |
Medical spa marketing services are provided by Moxie.
|
|
| Locked | Locked | Locked |
Distributor of RNA medicines
|
|
| Locked | Locked | Locked |
Healthcare marketing services are provided by CG Life.
|
|
| Locked | Locked | Locked |
Marketing communications services are delivered to businesses worldwide.
|
Detailed competitors of Harrow
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Harrow
Complete news archive for Harrow
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Harrow
Harrow was founded in 2012 and raised its 1st funding round 9 years after it was founded.
Harrow is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
As of Dec 31, 2024, the latest employee count at Harrow is 382.
Annual revenue of Harrow is $199.61M as on Dec 31, 2024.
Harrow, Inc. is dedicated to redefining eyecare through a comprehensive portfolio of ophthalmic pharmaceuticals. Solutions are developed to ensure safety, efficacy, and affordability for eyecare professionals and patients. The company operates in the rapidly growing ophthalmic market, offering essential medications, specialized compounding services, and branded therapies. Innovation and accessibility are prioritized to enhance patient outcomes and drive industry impact. Growth, operational excellence, and corporate responsibility are emphasized to shape the future of vision care. Access to high-quality, affordable treatments is ensured for the broader healthcare community.
Harrow's top competitors include Cardinal Health, Moxie and The Cigna Group.
Harrow offers Ophthalmic Medications, Compounding Business, and Branded Therapies.
Yes, Harrow is publicly traded on NASDAQ under the ticker symbol HROW.
Harrow has made 1 acquisition, including Melt Pharmaceuticals.
Harrow has 1 investor. Key investors include B. Riley Financial.
The ticker symbol of Harrow is HROW on NASDAQ.